Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features
Annals of Indian Psychiatry 2025 T. V. Pavan Kumar, Divya Bolla, Raj Kiran Donthu et al.
Abstract Depression is the leading cause of suicide, and antidepressants and modified electroconvulsive therapy (mECT) are the preferred treatment modalities. Ketamine is an established anesthetic agent and evidence for its use in depression is evolving. Here, we discuss the experience of treating severe depression with intravenous (IV) ketamine. A patient in his mid-forties presented with a...